Biochemical alterations in the follicular fluid of bovine peri-ovulatory follicles and association with final oocyte maturation. 2022

Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
N Abdulrahman Alrabiah, School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.

Follicular fluid (FF), a product of vascular transudate and granulosa and thecal cell secretions, is the milieu that has evolved to support oocyte growth and maturation which plays a central role in oocyte quality determination. Therefore, a suboptimal FF composition may be reflected in compromised oocyte progression through maturation, fertilization or embryo development. To date, the composition of bovine FF remains understudied. To address this, we comprehensively characterized the metabolomic constituency of bovine FF in the period during which the oocyte undergoes meiotic maturation. More specifically, FF from pre (-24 h) and peri (-2 h) -ovulatory follicles was profiled by high-throughput untargeted ultra-high-performance liquid chromatography tandem mass spectroscopy. A total of 634 metabolites were identified, comprising: lipids (37.1%), amino acids (30.0%), xenobiotics (11.5%), nucleotides (6.8%), carbohydrates (4.4%), cofactors and vitamins (4.4%), peptides (3.6%) and energy substrates (2.1%). The concentrations of 67 metabolites were significantly affected by stage of follicle development, 33.3% (n=21) were reduced (P≤0.05) by a mean of 9.0-fold, whereas 46 were elevated (P≤0.05) by a mean of 1.7-fold in peri vs. pre -ovulatory FF. The most pronounced individual metabolite concentration decreases were hypoxanthine (98.9-fold), xanthine (65.7-fold), 17β-oestradiol (12.4-fold), and inosine (4.6-fold). In contrast, the greatest increases were in retinal (4.9-fold), 1-methyl-5-imidazoleacetate (2.7-fold), and isovalerylcarnitine (2.7-fold). This global metabolomic analysis of bovine FF temporal dynamics provides new information for understanding the environment supporting oocyte maturation and facilitating ovulation, that has the potential for improving oocyte quality both in vivo and in vitro.

UI MeSH Term Description Entries

Related Publications

Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
November 2001, Biology of reproduction,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
April 2023, Human reproduction (Oxford, England),
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
January 2021, Frontiers in endocrinology,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
August 1976, Acta endocrinologica,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
January 1996, Biology of reproduction,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
August 1997, Ginecologia y obstetricia de Mexico,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
January 1986, Acta veterinaria Scandinavica,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
June 2020, Reproductive biomedicine online,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
March 1996, Theriogenology,
Noof Abdulrahman Alrabiah, and Constantine A Simintiras, and Alexander C O Evans, and Patrick Lonergan, and Trudee Fair
October 1980, Biology of reproduction,
Copied contents to your clipboard!